Vanderbilt University

Illumina Collaborates With Nashville Biosciences to Accelerate Medicines Development

Collaboration will transform new insights into drug discovery and therapy development through large-scale genomics
Press Release

SAN DIEGO, January 20, 2022 /3BL Media/ -- Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource.

Subscribe to Vanderbilt University